Table 1.
No. | DNA sequence | Size | Protein localisation |
Protein level | Inheritance
|
Phenotype
|
||||
---|---|---|---|---|---|---|---|---|---|---|
Affected family members* |
Thyroid dysfunction |
Choreoathetosis/ muscular hypotonia |
Pulmonary malfunction |
Sex | ||||||
1 | chr14:g (36042742_36142540)del |
99 798 bp | Entire protein | p.0 | AD | M 2 | Yes | Yes | Yes | M |
2 | chr14:g (35138127_37502915)del |
2 364 788 bp | Entire protein | p.0 | AD | M 1 | Yes | Yes | No | M |
3 | chr14:g (35221080_36553158)del |
1 332 078 bp | Entire protein | p.0 | n/a | n/a | No | Yes | No | F |
4 | chr14:g (36058432_36825446)del |
767 014 bp | Entire protein | p.0 | n/a | n/a | Yes | Yes | No | M |
5 | chr14:g (34071433_36246414)del |
2 174 981 bp | Entire protein | p.0 | n/a | n/a | Yes | Yes | No | F |
6 | chr14:g (31766511_46944545)del |
15 178 034 bp | Entire protein | p.0 | n/a | n/a | Yes | Yes | No | M |
7 | chr14:g (35883857_38226260)del |
2 342 403 bp | Entire protein | p.0 | AD | F 2 | Yes | Yes | Yes | M |
8 | chr14:g (35989750_36754641)del |
764 891 bp | Entire protein | p.0 | De novo | Nil | Yes | Yes | Yes | F |
9 | chr14:g (35257445_35257464 + 35257487_35984627)del |
727 181 bp | Del excluding NKX2-1 |
p.? | De novo | Nil | Yes | Yes | No | F |
10 | chr14:g (35801941_35878529)del |
76 588 bp | Del excluding NKX2-1 |
p.? | AD | M 2/F 2 | No | Yes | No | M |
11 | c.793delA | NK2 | p.Lys265LysfsX87 | De novo | Nil | Yes | Yes | No | M | |
12 | c.712delGG | NK2 | p.Gly238ArgfsX170 | AD | F 2 | Yes | Yes | Yes | M | |
13 | c.339delG | TN-HD | p.Trp113CysfsX16 | De novo | Nil | No | Yes | No | M | |
14 | c.796delGA | NK2 | p.Asp266Argfs142X | De novo | Nil | Yes | Yes | No | F | |
15 | c.157insC | TN-HD | p.Met53HisfsX355 | De novo | Nil | Yes | Yes | Yes | F | |
16 | c.866_883delinsCTACA | NK2-X | p.Gln289ProfsX59 | De novo | Nil | Yes | Yes | Yes | M | |
17 | c.544C>T | HD | p.Gln182X | De novo | Nil | Yes | Yes | Yes | F | |
18 | c.261C>A | TN-HD | p.Cys87X | AD | F 2 | Yes | Yes | Yes | M | |
19 | c.160C>T | TN-HD | p.Gln55X | Father n/a; mother WT |
n/a | Yes | Yes | No | F | |
20 | c.522C>G | HD | p.Tyr174X | n/a | n/a | Yes | Yes | Yes | M | |
21 | c.338G>A | TN-HD | p.Trp113X | n/a | n/a | Yes | Yes | No | M | |
22 | c.236C>A | TN-HD | p.Ser79X | AD | F 2 | Yes | Yes | No | F | |
23 | c.204C>G | TN-HD | p.Tyr68X | AD | F 1 | Yes | Yes | Yes | M | |
24 | [c.608C>G]+[c.613G>T] | HD | [p.Thr203Arg]+[p. Val205Phe] | AD/de | F 3 | Yes | Yes | No | M | |
25 | c.613G>T | HD | p.Val205Phe | De novo | Nil | Yes | Yes | No | F | |
26 | c.373+4A>G/r.373ins4 | TN-HD (splice donor site) | p.Ile155SerfsX126 | De novo | Nil | Yes | Yes | Yes | M | |
27 | c.373+5G>C/r.338_373del35 | TN-HD (splice donor site) | p.Trp143CysfsX138 | n/a | n/a | Yes | Yes | No | M | |
28 |
chr14:g (32446471_41666818)del |
9.2 Mbp | Entire protein | p.0 | De novo | Nil | Yes | Yes | Yes | M |
29 | c.585nsGG | HD | p.Leu195GlyfsX3 | De novo | Nil | Yes | Yes | Yes | M | |
30 | c.506C>A | HD | p.Ser169X | n/a | n/a | Yes | Yes | No | M | |
31 | c.261C>A | TN-HD | p.Cys87X | AD | F 1 | Yes | Yes | Yes | M | |
32 | c.613G>T | HD | p.Val205Phe | De novo | Nil | Yes | Yes | Yes | M |
Nomenclature for mutations according to recommendations of the Human Genome Variation Society (http://www.hgvs.org/mutnomen/); reference sequence REFSEQ Isoform 2 NM_003317.3; P, entire protein; HD, homeodomain; NK2, NK2-specific domain; AD, autosomal-dominant; n/a, information not available; TN-HD, sequence between tin- and homeodomain; M, male; F, female;
excluding index patient; mutations 29–32 as reported previously by authors.8
The italicised values refer to cases that have not been identified in the present genotyping study, but earlier in the Krude et al 2002 study8.